(NASDAQ: NTRA) Natera's forecast annual revenue growth rate of 18.72% is forecast to beat the US Diagnostics & Research industry's average forecast revenue growth rate of 8.35%, and it is also forecast to beat the US market's average forecast revenue growth rate of 13.6%.
Natera's revenue in 2026 is $2,306,113,000.On average, 23 Wall Street analysts forecast NTRA's revenue for 2026 to be $385,792,462,500, with the lowest NTRA revenue forecast at $366,233,550,000, and the highest NTRA revenue forecast at $400,815,975,000. On average, 23 Wall Street analysts forecast NTRA's revenue for 2027 to be $461,760,412,500, with the lowest NTRA revenue forecast at $430,296,075,000, and the highest NTRA revenue forecast at $497,901,881,250.
In 2028, NTRA is forecast to generate $549,208,593,750 in revenue, with the lowest revenue forecast at $492,232,631,250 and the highest revenue forecast at $630,420,600,000.